ATE182586T1 - Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung - Google Patents

Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung

Info

Publication number
ATE182586T1
ATE182586T1 AT94102183T AT94102183T ATE182586T1 AT E182586 T1 ATE182586 T1 AT E182586T1 AT 94102183 T AT94102183 T AT 94102183T AT 94102183 T AT94102183 T AT 94102183T AT E182586 T1 ATE182586 T1 AT E182586T1
Authority
AT
Austria
Prior art keywords
aminophthhaloylhydrazide
composition
application
pharmacological use
pertains
Prior art date
Application number
AT94102183T
Other languages
English (en)
Inventor
Lonid Minin
Slava Saizev
Original Assignee
Medinkor Zmm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinkor Zmm Ag filed Critical Medinkor Zmm Ag
Application granted granted Critical
Publication of ATE182586T1 publication Critical patent/ATE182586T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94102183T 1993-02-19 1994-02-12 Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung ATE182586T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH530/93A CH683965A5 (it) 1993-02-19 1993-02-19 Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.

Publications (1)

Publication Number Publication Date
ATE182586T1 true ATE182586T1 (de) 1999-08-15

Family

ID=4189123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94102183T ATE182586T1 (de) 1993-02-19 1994-02-12 Pharmakologische verwendung von 5- aminophthaloylhydrazide; ihre zusammensetzung und anwendung

Country Status (6)

Country Link
US (1) US5543410A (de)
EP (1) EP0617024B1 (de)
JP (1) JP2693373B2 (de)
AT (1) ATE182586T1 (de)
CH (1) CH683965A5 (de)
DE (1) DE69419640D1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2160104C2 (ru) * 1997-11-06 2000-12-10 Закрытое акционерное общество "Центр современной медицины "Медикор" Способ лечения язвенной болезни и лекарственный препарат для его осуществления
EP1203587B1 (de) 2000-03-28 2010-07-14 Abidov, Musea Tazhudinovich Arzneimittel und dessen herstellungsprozess
RU2211036C2 (ru) * 2001-11-20 2003-08-27 Общество с ограниченной ответственностью "Абидофарма" Лекарственный препарат (варианты) и способ его производства
US7326690B2 (en) * 2002-10-30 2008-02-05 Bach Pharma, Inc. Modulation of cell fates and activities by phthalazinediones
US6953799B1 (en) * 2002-10-30 2005-10-11 Bach Pharma, Inc. Modulation of cell fates and activities by diketo phthalazines
RU2233161C1 (ru) * 2003-04-18 2004-07-27 Общество с ограниченной ответственностью "Абидофарма" Лекарственный препарат (варианты) и способ его производства
US8592421B2 (en) 2003-08-04 2013-11-26 Valery Khazhmuratovich Zhilov Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
RU2326870C2 (ru) * 2003-08-04 2008-06-20 Валерий Хажмуратович ЖИЛОВ Применение циклических биоизостеров производных пуриновой системы для лечения расстройств, вызванных нарушениями нитрергической и дофаминергической систем
PL1781604T3 (pl) * 2004-06-23 2014-01-31 Synta Pharmaceuticals Corp Sole bis(tiohydrazydoamidu) do leczenia nowotworów
EP2393361B1 (de) * 2009-02-06 2016-12-07 Bach Pharma, Inc. Pharmazeutisch reine phthalazindione, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
WO2010096686A1 (en) 2009-02-19 2010-08-26 Bach Pharma, Inc. Methods of treating intestinal diseases and inflammatory conditions related to hiv-aids
AT509045B1 (de) * 2010-01-29 2011-06-15 Planta Naturstoffe Vertriebsges M B H Verbindungen zur behandlung von asthma bronchiale
PT2542535E (pt) 2010-03-01 2014-08-25 Metriopharm Ag Formas cristalinas para sal de sódio de 5-amino-2,3-di hidroftalazino-1,4-diona, preparações farmacêuticas contendo o mesmo e processo para a produção das ditas formas
AU2012232670A1 (en) 2011-03-23 2013-09-12 Ariel-University Research And Development Company Ltd. Treatment of proliferative disorders with a chemiluminescent agent
RU2577849C2 (ru) * 2013-09-25 2016-03-20 Общество с ограниченной ответственностью "Сэлвим" Бис(5-амино-1,4-диоксо-1,2,3,4-тетрагидрофталазин-2-ил)цинк, способ его получения, фармацевтическая композиция на его основе, лечебные средства на его основе, способ лечения кожных заболеваний и способ лечения гастрита
WO2016096143A1 (de) 2014-12-18 2016-06-23 Metriopharm Ag Kristalline form von 5-amino-2,3-dihydrophthalazin-1,4-dion natriumsalz, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
EP3248602A1 (de) * 2016-05-26 2017-11-29 MetrioPharm AG Verwendung von 5-amino-2,3-dihydro-1,4-phthalazindion bei der behandlung von entzündlichen und/oder degenerativen erkrankungen der sehnen, gelenkbänder, gelenkkapseln und schleimbeutel
US20210379063A1 (en) * 2018-10-26 2021-12-09 Immunopharma Plus D.O.O. Oral aminodihydrophthalazinedione compositions and their use in the treatment of non-viral hepatitis
EP3858358A1 (de) * 2020-01-31 2021-08-04 MetrioPharm AG Verwendung von 5-amino-2,3-dihydro-1,4-phthalazindion zur behandlung von seltenen chronischen entzündlichen lungenerkrankungen
RU2747467C1 (ru) * 2020-07-17 2021-05-05 Муса Тажудинович Абидов Способ защиты от коронавирусной инфекции

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2453578A (en) * 1944-02-19 1948-11-09 American Cyanamid Co Preparation of chemiluminescent composition of matter
GB1100911A (en) * 1963-08-20 1968-01-24 Benger Lab Ltd Phthalazine derivatives
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
JPS5116430B2 (de) * 1971-08-05 1976-05-24
JPS5023689B2 (de) * 1971-11-29 1975-08-09
US3957776A (en) * 1973-02-28 1976-05-18 Delmar Chemicals Limited Novel phthalazinone compounds
US4011219A (en) * 1975-03-28 1977-03-08 Chugai Seiyaku Kabushiki Kaisha Phthalazine derivatives and salts thereof
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
US4355165A (en) * 1978-07-24 1982-10-19 Miles Laboratories, Inc. Amino-functionalized phthalhydrazide intermediates
US4226993A (en) * 1978-07-24 1980-10-07 Miles Laboratories, Inc. Amino-functionalized phthalhydrazides
US4334069A (en) * 1978-07-24 1982-06-08 Miles Laboratories, Inc. Chemiluminescent phthalhydrazide-labeled hapten conjugates
US4250180A (en) * 1979-07-16 1981-02-10 Ortho Pharmaceutical Corporation Method of treating arrhythmia
DE3164437D1 (en) * 1980-08-25 1984-08-02 Kabivitrum Ab Peptide substrates for determination of protease activity
HU181184B (en) * 1980-09-12 1983-06-28 Eszakmagyar Vegyimuevek Composition for replacing kinetine,the effect and membraneactivity of which is similar to citokinine,which composition improves plant productivity,quantity of protein-nitrogen and anion-absorptivity
US4440763A (en) * 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
US4665181A (en) * 1984-05-17 1987-05-12 Pennwalt Corporation Anti-inflammatory phthalazinones
US5391555A (en) * 1991-11-12 1995-02-21 Miles Inc. Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors
CH683966A5 (it) * 1993-02-19 1994-06-30 Limad Marketing Exp & Imp Composti della classe dei ftalidrazidici come sostanze attive in agenti anti-ipossici e di difesa.

Also Published As

Publication number Publication date
US5543410A (en) 1996-08-06
EP0617024B1 (de) 1999-07-28
JP2693373B2 (ja) 1997-12-24
CH683965A5 (it) 1994-06-30
DE69419640D1 (de) 1999-09-02
EP0617024A1 (de) 1994-09-28
JPH07179431A (ja) 1995-07-18

Similar Documents

Publication Publication Date Title
DE69419640D1 (de) Pharmakologische Verwendung von 5-Aminophthaloylhydrazide; ihre Zusammensetzung und Anwendung
EE03741B1 (et) N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine
FI954718A7 (fi) Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitam iseksi
SE9604786D0 (sv) New compounds
FI943421L (fi) 1,5-bentsodiatsepiinijohdannaiset ja niiden käyttö lääkkeenä
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
FI945281L (fi) Heterosykliset yhdisteet, niiden valmistus ja käyttö
DE69027057D1 (de) Retinal, dessen Derivate und deren therapeutische Verwendung
FI955336A7 (fi) Varjoaineina käytettäviä trisyklopolyatsamakrosyklofosfonihappoja, nii den komplekseja ja johdannaisia
FI970489L (fi) Paikallisesti käytettäviä silmälääkekoostumuksia, jotka sisältävät doksepiinijohdoksia ja soveltuvat allergisten silmäsairauksien hoitoon
DK0425650T3 (da) Antiinflammatoriske 4-aminophenolderivater
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
ES2150989T3 (es) Nuevos derivados de quinoxalinadiona, su preparacion y empleo en medicamentos.
DE3785602D1 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
FI941068A7 (fi) Bentsoksatsiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
DE69414194D1 (de) Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren
ATE168988T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
FI954229L (fi) Heterosykliset yhdisteet, niiden käyttö ja valmistus
FI961977A7 (fi) N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja kä yttö
DE59508900D1 (de) Verwendung von Dibrom-thiophen-carbonsäure-Derivaten als Mikrobizide
FI925850A7 (fi) Pyridyylitiatsolidinikarboksyylihapon amidijohdannaiset, niiden valmistus ja niiden terapeuttiset käytöt
FI955386A7 (fi) 4-p-fluoribentsoyyli-1-piperidinyyli-propoksi-kromen-4-onijohdannaiset , niiden valmistus ja käyttö psykoosin ja skitsofrenian hoidossa